Literature DB >> 24932146

Obstructive sleep apnea, obesity, and the development of acute respiratory distress syndrome.

Lioudmila V Karnatovskaia1, Augustine S Lee1, S Patrick Bender2, Daniel Talmor3, Emir Festic1.   

Abstract

BACKGROUND: Obstructive sleep apnea (OSA) may increase the risk of respiratory complications and acute respiratory distress syndrome (ARDS) among surgical patients. OSA is more prevalent among obese individuals; obesity can predispose to ARDS. HYPOTHESIS: It is unclear whether OSA independently contributes towards the risk of ARDS among hospitalized patients.
METHODS: This is a pre-planned retrospective subgroup analysis of the prospectively identified cohort of 5,584 patients across 22 hospitals with at least one risk factor for ARDS at the time of hospitalization from a trial by the US Critical Illness and Injury Trials Group designed to validate the Lung Injury Prediction Score. A total of 252 patients (4.5%) had a diagnosis of OSA at the time of hospitalization; of those, 66% were obese. Following multivariate adjustment in the logistic regression model, there was no significant relationship between OSA and development of ARDS (OR = 0.65, 95%CI = 0.32-1.22). However, body mass index (BMI) was associated with subsequent ARDS development (OR = 1.02, 95%CI = 1.00-1.04, p = 0.03). Neither OSA nor BMI affected mechanical ventilation requirement or mortality.
CONCLUSIONS: Prior diagnosis of OSA did not independently affect development of ARDS among patients with at least one predisposing condition, nor the need for mechanical ventilation or hospital mortality. Obesity appeared to independently increase the risk of ARDS.

Entities:  

Keywords:  acute respiratory distress syndrome; obesity; obstructive sleep apnea

Mesh:

Year:  2014        PMID: 24932146      PMCID: PMC4031407          DOI: 10.5664/jcsm.3794

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  42 in total

1.  The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation.

Authors:  Jesús Villar; Jesús Blanco; José Manuel Añón; Antonio Santos-Bouza; Lluís Blanch; Alfonso Ambrós; Francisco Gandía; Demetrio Carriedo; Fernando Mosteiro; Santiago Basaldúa; Rosa Lidia Fernández; Robert M Kacmarek
Journal:  Intensive Care Med       Date:  2011-10-14       Impact factor: 17.440

2.  Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study.

Authors:  Ognjen Gajic; Ousama Dabbagh; Pauline K Park; Adebola Adesanya; Steven Y Chang; Peter Hou; Harry Anderson; J Jason Hoth; Mark E Mikkelsen; Nina T Gentile; Michelle N Gong; Daniel Talmor; Ednan Bajwa; Timothy R Watkins; Emir Festic; Murat Yilmaz; Remzi Iscimen; David A Kaufman; Annette M Esper; Ruxana Sadikot; Ivor Douglas; Jonathan Sevransky; Michael Malinchoc
Journal:  Am J Respir Crit Care Med       Date:  2010-08-27       Impact factor: 21.405

3.  Obstructive sleep apnoea and perioperative complications in bariatric patients.

Authors:  T N Weingarten; A S Flores; J A McKenzie; L T Nguyen; W B Robinson; T M Kinney; B T Siems; P J Wenzel; M G Sarr; M S Marienau; D R Schroeder; E J Olson; T I Morgenthaler; D O Warner; J Sprung
Journal:  Br J Anaesth       Date:  2010-10-18       Impact factor: 9.166

Review 4.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

Review 5.  Obesity and obstructive sleep apnea--clinical significance of weight loss.

Authors:  Henri Tuomilehto; Juha Seppä; Matti Uusitupa
Journal:  Sleep Med Rev       Date:  2012-10-16       Impact factor: 11.609

6.  Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients.

Authors:  Ashish Agrawal; Michael A Matthay; Kirsten N Kangelaris; John Stein; Jeffrey C Chu; Brandon M Imp; Alfredo Cortez; Jason Abbott; Kathleen D Liu; Carolyn S Calfee
Journal:  Am J Respir Crit Care Med       Date:  2013-04-01       Impact factor: 21.405

7.  Identification of patients at risk for postoperative respiratory complications using a preoperative obstructive sleep apnea screening tool and postanesthesia care assessment.

Authors:  Bhargavi Gali; Francis X Whalen; Darrell R Schroeder; Peter C Gay; David J Plevak
Journal:  Anesthesiology       Date:  2009-04       Impact factor: 7.892

8.  Leptin resistance protects mice from hyperoxia-induced acute lung injury.

Authors:  Amy Bellmeyer; Janice M Martino; Navdeep S Chandel; G R Scott Budinger; David A Dean; Gökhan M Mutlu
Journal:  Am J Respir Crit Care Med       Date:  2006-12-21       Impact factor: 21.405

9.  Leptin, obestatin and apelin levels in patients with obstructive sleep apnoea syndrome.

Authors:  Sabine Zirlik; Tabea Hauck; Florian Siegfried Fuchs; Markus Friedrich Neurath; Peter Christopher Konturek; Igor Alexander Harsch
Journal:  Med Sci Monit       Date:  2011-02-25

10.  KL-6 concentration in pulmonary epithelial lining fluid is a useful prognostic indicator in patients with acute respiratory distress syndrome.

Authors:  Tomohiro Kondo; Noboru Hattori; Nobuhisa Ishikawa; Hiroshi Murai; Yoshinori Haruta; Nobuyuki Hirohashi; Koichi Tanigawa; Nobuoki Kohno
Journal:  Respir Res       Date:  2011-03-22
View more
  12 in total

Review 1.  Mouse Modeling of Obese Lung Disease. Insights and Caveats.

Authors:  Benjamin T Suratt
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

2.  Obstructive Sleep Apnea without Obesity Is Common and Difficult to Treat: Evidence for a Distinct Pathophysiological Phenotype.

Authors:  Emma L Gray; David K McKenzie; Danny J Eckert
Journal:  J Clin Sleep Med       Date:  2017-01-15       Impact factor: 4.062

3.  Application of alveolar recruitment strategy and positive end-expiratory pressure combined with autoflow in the one-lung ventilation during thoracic surgery in obese patients.

Authors:  Zhi-Guo Shi; Wan-Ming Geng; Guang-Kuo Gao; Chun Wang; Wei Liu
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 2.895

4.  Independent factors related to preoperative acute lung injury in 130 adults undergoing Stanford type-A acute aortic dissection surgery: a single-center cross-sectional clinical study.

Authors:  Xudong Pan; Jiakai Lu; Weiping Cheng; Yanwei Yang; Junming Zhu; Mu Jin
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

5.  Unanticipated Respiratory Compromise and Unplanned Intubations on General Medical and Surgical Floors.

Authors:  Armando D Bedoya; Nrupen A Bhavsar; Bhargav Adagarla; Courtney B Page; Benjamin A Goldstein; Neil R MacIntyre
Journal:  Respir Care       Date:  2020-03-10       Impact factor: 2.339

6.  Suboptimal Clinical Documentation in Young Children with Severe Obesity at Tertiary Care Centers.

Authors:  Cassandra C Brady; Vidhu V Thaker; Todd Lingren; Jessica G Woo; Stephanie S Kennebeck; Bahram Namjou-Khales; Ashton Roach; Jonathan P Bickel; Nandan Patibandla; Guergana K Savova; Imre Solti; Ingrid A Holm; John B Harley; Isaac S Kohane; Nancy A Crimmins
Journal:  Int J Pediatr       Date:  2016-09-06

7.  "Obesity Paradox" in Acute Respiratory Distress Syndrome: Asystematic Review and Meta-Analysis.

Authors:  Guo Zhi; Wang Xin; Wang Ying; Xing Guohong; Liu Shuying
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

Review 8.  AMPK and the Need to Breathe and Feed: What's the Matter with Oxygen?

Authors:  A Mark Evans; D Grahame Hardie
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 6.208

Review 9.  Down Syndrome and COVID-19: A Perfect Storm?

Authors:  Joaquin M Espinosa
Journal:  Cell Rep Med       Date:  2020-05-01

Review 10.  Obstructive Sleep Apnea, Obesity, and Noninvasive Ventilation: Considerations During the COVID-19 Pandemic.

Authors:  Colin M Suen; David S C Hui; Stavros G Memtsoudis; Frances Chung
Journal:  Anesth Analg       Date:  2020-08       Impact factor: 6.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.